14 results on '"Wiesław, Kryczka"'
Search Results
2. 816 RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR CONTAINING TRIPLE THERAPY DOES NOT AFFECT EARLY VIROLOGIC RESPONSE IN NON-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSIS
3. P1169 EFFECT OF PEGYLATED INTERFERON OR RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR BASED THERAPY ON SVR12 IN NULL-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSIS (ADVEX STUDY)
4. The phenotype of inflammatory infiltrate in acute (AVHC) and chronic (CVHC) type C hepatitis — A comparative analysis
5. Histopathological and immunohistochemical features of acute type C hepatitis
6. 4 ONCE DAILY ALISPORIVIR (DEB025) PLUS PEGIFNALFA2A/RIBAVIRIN RESULTS IN SUPERIOR SUSTAINED VIROLOGIC RESPONSE (SVR24) IN CHRONIC HEPATITIS C GENOTYPE 1 TREATMENT NAIVE PATIENTS
7. 748 EFFICACY OF STANDARD OF CARE THERAPY FOLLOWING EXPERIMENTAL DEBIO 025 TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C
8. 143 EFFICACY AND SAFETY OF INCREASING DOSES OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A IN TREATMENT NAIVE CHRONIC HCV PATIENTS
9. The significance of hepatic steatosis (HS) in chronic hepatitis B and C
10. HGV and fulminant Wilson's disease. Case reports
11. Nonalcoholic steatohepatitis (NASH) as diagnostic problem
12. Drug-induced acute hepatitis
13. Outcome of acute hepatitis B and C
14. HGV RNA in acute non A-C hepatitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.